DI BENEDETTO, Antonino
 Distribuzione geografica
Continente #
EU - Europa 11.226
NA - Nord America 9.454
AS - Asia 5.000
SA - Sud America 1.695
Continente sconosciuto - Info sul continente non disponibili 256
AF - Africa 178
OC - Oceania 8
Totale 27.817
Nazione #
US - Stati Uniti d'America 9.261
RU - Federazione Russa 5.044
SG - Singapore 2.175
CN - Cina 1.479
BR - Brasile 1.454
IT - Italia 1.252
IE - Irlanda 1.218
SE - Svezia 1.085
DE - Germania 631
FR - Francia 580
HK - Hong Kong 490
UA - Ucraina 468
FI - Finlandia 262
GB - Regno Unito 255
VN - Vietnam 237
PL - Polonia 169
IN - India 125
BD - Bangladesh 87
AR - Argentina 77
CA - Canada 74
TR - Turchia 58
IQ - Iraq 57
MX - Messico 55
NL - Olanda 53
EC - Ecuador 50
BE - Belgio 46
ZA - Sudafrica 43
EG - Egitto 39
ES - Italia 35
JP - Giappone 35
AT - Austria 29
MA - Marocco 28
ID - Indonesia 26
PK - Pakistan 26
CO - Colombia 25
CZ - Repubblica Ceca 23
UZ - Uzbekistan 23
SA - Arabia Saudita 22
IR - Iran 18
VE - Venezuela 18
AZ - Azerbaigian 17
UY - Uruguay 17
DZ - Algeria 16
JM - Giamaica 15
TN - Tunisia 14
CL - Cile 13
IL - Israele 13
PE - Perù 13
PY - Paraguay 13
JO - Giordania 12
KE - Kenya 11
LT - Lituania 11
PH - Filippine 11
CH - Svizzera 10
AE - Emirati Arabi Uniti 9
BO - Bolivia 9
KG - Kirghizistan 9
LB - Libano 9
NP - Nepal 9
CI - Costa d'Avorio 8
GT - Guatemala 8
RO - Romania 8
BG - Bulgaria 7
KZ - Kazakistan 7
MY - Malesia 7
SN - Senegal 7
AU - Australia 6
GE - Georgia 6
GR - Grecia 6
KR - Corea 6
NI - Nicaragua 6
PA - Panama 6
SY - Repubblica araba siriana 6
BB - Barbados 5
CR - Costa Rica 5
EU - Europa 5
GY - Guiana 5
LV - Lettonia 5
MD - Moldavia 5
AL - Albania 4
DO - Repubblica Dominicana 4
EE - Estonia 4
HN - Honduras 4
HU - Ungheria 4
PS - Palestinian Territory 4
RS - Serbia 4
BH - Bahrain 3
NG - Nigeria 3
OM - Oman 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BW - Botswana 2
BY - Bielorussia 2
GD - Grenada 2
LU - Lussemburgo 2
MN - Mongolia 2
MU - Mauritius 2
PR - Porto Rico 2
QA - Qatar 2
SV - El Salvador 2
Totale 27.547
Città #
Moscow 1.445
Ashburn 1.334
Singapore 1.226
Dublin 1.218
Chandler 970
Jacksonville 894
Dallas 824
Nyköping 545
Beijing 541
Hong Kong 487
San Jose 474
Council Bluffs 320
The Dalles 219
Princeton 212
Boardman 199
Los Angeles 198
Cambridge 195
Lauterbourg 190
Dearborn 175
Messina 170
Des Moines 162
Medford 155
Warsaw 154
Ann Arbor 147
Munich 126
São Paulo 122
Buffalo 98
New York 88
Bremen 72
Ho Chi Minh City 69
Jinan 67
Milan 66
Tianjin 66
Santa Clara 65
Wilmington 63
Shenyang 57
Florence 56
Rome 55
Woodbridge 55
Redondo Beach 54
Frankfurt am Main 53
Turku 50
Guangzhou 46
Brussels 45
Hanoi 44
Lancaster 44
Orem 44
San Mateo 40
Belo Horizonte 38
Catania 36
Rio de Janeiro 34
Düsseldorf 33
Cairo 32
Columbus 31
Tokyo 30
Brooklyn 29
Nanjing 29
Seattle 29
Naples 28
Chennai 27
Pune 27
Atlanta 26
Chicago 26
Curitiba 26
Zhengzhou 26
Haikou 25
Phoenix 25
Hebei 24
Houston 24
London 24
Montreal 24
Shanghai 24
Brasília 23
Johannesburg 23
Quito 23
San Francisco 22
Baghdad 21
Denver 21
Porto Alegre 20
Salvador 20
Tashkent 20
Hangzhou 19
Ningbo 19
Washington 19
Helsinki 18
Shenzhen 18
Stockholm 18
Boston 17
Guayaquil 17
Mexico City 17
Manchester 16
Nuremberg 16
Olomouc 16
Vienna 16
Bologna 15
Guarulhos 15
Hyderabad 15
Montevideo 15
Baku 14
Da Nang 14
Totale 15.183
Nome #
VALUTAZIONE DEI LIVELLI DI LIPOPROTEINA(A) ED INSULINA DURANTE E DOPO LA GRAVIDANZA. DATI PRELIMINARI 897
SCLEROSTIN AND DICKKOPF-1 LEVELS IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 273
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial 253
"Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL. 239
1ST-PHASE INSULIN-RESPONSE TO INTRAVENOUS GLUCOSE IN CYSTIC- FIBROSIS PATIENTS WITH DIFFERENT DEGREES OF GLUCOSE-TOLERANCE 237
Altered platelet magnesium and plasma and urinary soluble form of intercellular adhesion molecule I (sICAM-1) concentrations in insulin dependent diabetes mellitus (IDDM) patients with microalbuminuria. 232
Adiponectin and insulin resistance in early- and late-onset pre-eclampsia 231
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria 224
Depressione, ansia e rabbia in soggetti affetti da diabete mellito di tipo 1 [Depression, anxiety and anger in patients with type 1 diabetes mellitus] 223
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial 220
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 219
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 216
Personality, Alexithymia, and Anger in a sample of adults affected by Type 1 Juvenile-Onset Diabetes. 214
Italian risk factor-based screening for gestational diabetes. 211
Association between maternal serum high mobility group box 1 levels and pregnancy complicated by gestational diabetes mellitus 210
A single abnormal value of the glucose tolerance test is related to increased adverse perinatal outcome. 209
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy 207
Different concentration of human cord blood HMGB1 according to delivery and labour: A pilot study 207
Erectile dysfunction in compensated liver cirrhosis 204
A GENETIC-POLYMORPHISM OF THE APOLIPOPROTEIN AI-CIII GENE- CLUSTER IS ASSOCIATED WITH CORONARY HEART-DISEASE IN NON- INSULIN-DEPENDENT DIABETES-MELLITUS 203
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 203
High Prevalence of Arcobacter Carriage in Older Subjects with Type 2 Diabetes 199
Age and metabolic control influence lens opacity in type I, insulin-dependent diabetic patients 197
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 196
Myo-inositol may prevent gestational diabetes in PCOS women 195
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 194
EFFETTO DEL POLIMORFISMO CETP TAQ1B SUL PROFILO LIPIDICO E SULLE SOTTOPOLAZIONI HDL NELLE DONNE CON E SENZA DIABETE DI TIPO 2 188
C-reactive protein as an early predictor of gestational diabetes mellitus 186
Epidemiology of intensive care unit-acquired sepsis in Italy: Results of the SPIN-UTI network 186
Cardiac diastolic evaluation in pregnant women with abnormal glucose tolerance: an opportunity to detect the early and subclinical alterations and prevent cardiovascular diseases 184
Ocular surface changes in type 1 diabetic patients. 184
Effects of myo-inositol on glucose variability in women with gestational diabetes 184
Anticorpi anti P-53 in pazienti con diabete mellito di tipo 1 183
SCLEROSTIN LEVELS IN TYPE 1 DIABETES MELLITUS: GENEDER DIFFERENCES AND ASSOCIATION WITH CLINICAL FEATURES 182
Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. 172
First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes 171
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome 171
APOLIPOPROTEIN A1 GENE PROMOTER POLYMORPHISM AND CORONARY HEART-DISEASE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS 169
Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis 169
The complex interplay between clinical and person-centered diabetes outcomes in the two genders 169
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 169
Carotid atherosclerosis and lipid profile in a diabetic population: a retrospective evaluation 168
Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance 166
Nuove evidenze sul ruolo della supplementazione con inositolo nel diabete gestazionale 166
Anti-p53 autoantibodies in patients with IDDM 165
Correlates of total homocysteine plasma concentration in type 2 diabetes 164
Improvement of selective screening strategy for gestational diabetes through a more accuratedefinition of high-risk groups 164
Hypoplastic nails and brachydactyly in a girl with moderate acne and hirsutism 164
Epatite C: un fattore di rischio per il diabete? 163
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 162
Age and metabolic control influence lens opacity in IDDM patients 161
Myo-inositol supplementation and the onset of gestational diabetes mellitus in pregnant women with a family hystory of type 2 diabetes. A prospective, randomized, placebo controlled study 161
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes–a randomized and open-label, placebo-controlled clinical trial 160
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 159
CORRESPONDENCE BETWEEN FIRST TRIMESTER FASTING GLICEMIA AND ORAL GLUCOSE TOLERANCE TEST IN GESTATIONAL DIABETES DIAGNOSIS 158
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 157
Serum thyroid hormone autoantibodies in type 1 diabetes mellitus 157
High mobility group protein B1: a new biomarker of obesity in pregnant women? 157
Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders 151
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 151
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 151
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 151
GENDER DIFFERENCES IN THE RELATIONSHIP BETWEEN METABOLIC SYNDROME AND ANGER EXPRESSION. 149
Epatite C: un fattore di rischio per il diabete? 148
A multicenter Italian study on pregnancy outcome in women with diabetes 148
CAROTID ATHEROSCLEROSIS AND LIPID PROFILE IN A DIABETIC POPULATION: A RETROSPECTIVE EVALUATION 147
C-reactive protein as an early predictor of gestational diabetes mellitus. 147
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica 146
Is diabetes mellitus a risk factor for HCV infection? 145
Alterazioni della funzione urodinamica nel diabete mellito di tipo 2 144
A computerized network of diabetes clinics as a tool for quality of care improvement: the experience of Club Diabete Sicili@ 143
Studio eco-strain degli effetti del trattamento con Genisteina sul ventricolo sinistro in donne in post-menopausa con sindome metabolica (Strain-Echo Assessment of Left Ventricular Effects of Genistein Treatment in Post-Menopausal Women with Metabolic Syndrome). 143
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 142
Midtrimester Amniotic Fluid Leptin and Insulin Levels and Subsequent Gestational Diabetes. 141
Relationship between serum erythropoietin levels and rT3, T4 concentrations in elderly patients with non-thyroidal illnesses 141
Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women. 141
Myoinositol plus α‑lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study 141
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 139
Algorithms for personalized therapy of type 2 diabetes: results of a web-based international survey 139
APOLIPOPROTEIN-B AND APOLIPOPROTEIN-A-I/C-III GENETIC POLYMORPHISMS AND CORONARY HEART-DISEASE IN DIABETES-MELLITUS 138
Magnesium levels in plasma, erythrocyte, and platelet in hypertensive and normotensive patients with type II diabetes mellitus 138
La disfunzione diastolica nel diabete gestazionale 138
DIFFERENT DAILY BLOOD GLUCOSE CONTROL AND FREE INSULIN LEVELS DURING TREATMENT WITH MIXTURES OF SOLUBLE AND LENTE OR SOLUBLE AND NPH SEMISYNTHETIC HUMAN INSULINS. 138
EFFETTO DEL DIABETE E DELLA MENOPAUSA SUL PROFILO LIPIDICO E LA DISTRIBUZIONE DELLE SOTTOPOPOLAZIONI HDL NELLE DONNE 137
Four-year follow-up of glucose tolerance and beta-cell function in nondiabetic cystic fibrosis patients. 137
The impact of clinical and psychological characteristics on alexithymia in type 1 diabetes 137
Factors affecting diabetes mellitus onset in cystic fibrosis: Evidence from a 10-year follow-up study 136
Genistein Supplementation and Cardiac Function in Postmenopausal Women with Metabolic Syndrome: Results from a Pilot Strain-Echo Study 135
A preliminary study of the use of telemedicine system for monitoring diabetes during pregnancy 133
AMD Annals: a model of continuous monitoring and improvement of the quality of diabetes care 133
Prevalenza dei fattori di rischio associati al diabete gestazionale e alla ridotta tolleranza glucidica in gravidanza 131
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity 131
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review 131
Prevalence of risk factors in the screening of carbohydrate intolerance in pregnancy 129
VALUTAZIONE LONGITUDINALE DI DONNE CON RIDOTTA TOLLERANZA GLUCIDICA IN GRAVIDANZA 127
Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study 127
Mild hyperhomocysteinemia and the common C677t polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes. 124
Predittività dell’OGTT sugli outcomes clinici ed ostetrici nella ridotta tolleranza glucidica in gravidanza 120
La disfunzione diastolica nel diabete gestazionale 119
Skin lesions in diabetes mellitus: prevalence and clinical correlations. 118
Totale 17.537
Categoria #
all - tutte 93.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.273


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.208 0 0 26 47 47 25 113 66 29 286 163 406
2022/20233.769 276 295 178 297 357 395 26 212 1.552 21 116 44
2023/2024983 79 157 65 123 74 158 34 56 0 40 6 191
2024/20254.241 58 59 96 258 192 161 80 874 1.072 256 432 703
2025/202611.931 598 816 817 732 904 2.641 1.477 1.486 1.537 473 235 215
2026/2027929 237 647 45 0 0 0 0 0 0 0 0 0
Totale 27.817